Banaja signs agreement with Qatar Pharma

01 Jun 2010

(MENAFN) Banaja Pharmaceuticals said that it has signed an agreement with Qatar Infusions Factory (Qatar Pharma) to distribute Qatar Pharma?s products in Saudi Arabia, Reuters reported.

The Chief Executive Officer at Banaja said that the agreement is the first of its kind demonstrating enhanced cooperation between the two countries in the healthcare sector and strengthening economic ties.

Due to increasing demand, the health care market in the GCC is expected to grow at about nine percent annually to reach between $47 billion and $55 billion by 2020, according to analysts.

More News

This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more